U.S. Hospitality Stock News

In early September 2025, Zai Lab announced that the final analysis of its Phase 3 FORTITUDE-101 trial in gastric cancer indicated the previously reported survival benefit with bemarituzumab plus chemotherapy had diminished compared to the interim results, leading the company to delay regulatory filing until results from another confirmatory trial are available. This development prompted a legal investigation into the company’s disclosures and highlights the heightened scrutiny around pivotal...

Bruker (BRKR) has been making headlines this week after completing a $600 million mandatory convertible preferred stock offering. This move is designed to pay down outstanding loans and strengthen the balance sheet. While this type of capital raise can sometimes prompt concerns about share dilution, the company’s focus is on fortifying financial flexibility and freeing up resources for future growth opportunities. For investors on the sidelines, this update offers a timely reason to revisit...

Last week, dLocal Limited's major shareholder General Atlantic completed a secondary offering of 17,250,000 Class A common shares at US$12.75 per share, with no proceeds going to dLocal itself. This sell-down increases the company's free float, potentially enhancing liquidity, but does not impact its operations or capital position. Next, we'll explore how this significant shareholder exit impacts dLocal's investment narrative and signals evolving sentiment among long-term holders. Uncover...

Insperity (NSP) has landed squarely in the market spotlight after a string of tough headlines. The company reported disappointing second-quarter earnings, missed estimates, and quickly followed it up by cutting its full-year forecast, blaming higher benefits and pharmacy costs. If that was not enough to shake investor confidence, a legal investigation, launched by Bragar Eagel & Squire, P.C. for possible violations of federal securities laws, added another layer of uncertainty and sent shares...

If you are watching Pfizer (NYSE:PFE) right now, this new collaboration with Olema Pharmaceuticals is the kind of news that could prompt a second look. The two companies have announced a clinical trial partnership to test Pfizer’s investigational CDK4 inhibitor in combination with Olema’s palazestrant for metastatic breast cancer. This expands Pfizer’s reach in targeted oncology. For investors, this new agreement builds on Pfizer’s pipeline strategy and keeps the spotlight on potential new...

Hormel Foods Corporation recently reported its third-quarter 2025 results, showing year-over-year gains in sales and net income, but simultaneously lowered its full-year earnings and operating income guidance for 2025. This downward revision in outlook, issued alongside otherwise positive quarterly results, reflects heightened concerns over future profitability and operating performance amid ongoing cost and demand pressures. We'll examine how Hormel Foods' lowered full-year earnings...

TriCo Bancshares recently announced an increase in its quarterly dividend, with shareholders set to receive the higher payout on September 19, 2025. This move, along with several analyst outlook upgrades, highlights growing confidence in the company's direction and potential for shareholder returns. We'll explore how the dividend increase strengthens TriCo Bancshares' investment narrative and highlights its shareholder-focused approach. The end of cancer? These 29 emerging AI stocks are...

In recent days, Truist Financial initiated coverage on Revolution Medicines, highlighting the company's pipeline targeting RAS-mutant cancers and the promise of its lead drug candidate, daraxonrasib. This positive attention points to growing recognition of Revolution Medicines' novel approach to combination cancer therapies, which some believe is not yet fully appreciated by the market. We'll explore how Truist's emphasis on the innovative combination therapies pipeline could influence...

Badger Meter (BMI) is in the spotlight this week after JPMorgan initiated analyst coverage, highlighting the company’s evolution in water technology. The real buzz comes from Badger Meter’s advancement into advanced metering infrastructure and analytics, aiming to help cities manage water more efficiently. This renewed attention follows a second-quarter dip in the stock, with JPMorgan pointing to the recent pullback as a moment investors might want to watch. Over the past year, Badger Meter’s...

Yum! Brands announced several executive leadership changes, including Chris Turner becoming CEO and Board Director, Ranjith Roy named as CFO, and promotions of Sean Tresvant and Jim Dausch to expanded roles across the enterprise. These appointments reflect a company-wide emphasis on global consumer engagement, digital innovation, and operational scale, as well as important transitions at the very top amid David Gibbs' retirement. We'll explore how appointing a new CEO and CFO may influence...

Earlier this week, Brink's reported second quarter revenues surpassing analyst forecasts by 2.1%, fueled by higher-margin subscription-based revenues and strengthening operational efficiency. This performance led the company to raise its full-year expectations, highlighting a business model shift that stands out against mixed results from other security service providers. We'll explore how Brink's accelerated growth in subscription revenues and improved outlook influence its investment...

Doximity recently reported strong second-quarter results, with revenue up 15.2% year on year and key metrics outperforming analyst estimates. Leadership highlighted record engagement and profit growth, attributing success to the continued traction of their newsfeed, workflow, and AI tools in the clinician community. We'll explore how record engagement across Doximity's AI and workflow products could influence the company's longer-term investment narrative. Trump has pledged to "unleash"...

Cheniere Energy (LNG) has been catching the spotlight after its CEO took center stage at the Gastech Exhibition & Conference 2025. For investors trying to decide what to do next, this kind of high-profile presentation can raise the stakes. These industry gatherings are more than just networking opportunities; they are often where leaders share insights on strategy, emerging trends, and what might be coming down the pipeline for the company and the sector as a whole. Against this backdrop of...

Alaska Air Group (ALK) just made headlines with its latest international push: the company’s flagship airline is set to launch nonstop flights from Seattle to Reykjavík, Iceland, starting May 2026. Even more intriguing, Alaska Airlines is joining forces with Icelandair, enabling travelers to reach a host of European destinations on a single ticket. For investors weighing their next move, this combination of new route and strategic partnership signals a bolder play in the transatlantic...

Key Insights Scholastic's Annual General Meeting to take place on 17th of September Total pay for CEO Peter Warwick...

With a median price-to-earnings (or "P/E") ratio of close to 19x in the United States, you could be forgiven for...

Some Apollo Global Management, Inc. ( NYSE:APO ) shareholders may be a little concerned to see that insider Leon Black...

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Dole plc...

Leggett & Platt, Incorporated ( NYSE:LEG ) stock is about to trade ex-dividend in 4 days. The ex-dividend date is...

The Brand House Collective, Inc. ( NASDAQ:TBHC ) shareholders have had their patience rewarded with a 61% share price...

It looks like Domino's Pizza, Inc. ( NASDAQ:DPZ ) is about to go ex-dividend in the next 4 days. The ex-dividend date...

FuelCell Energy, Inc.'s ( NASDAQ:FCEL ) price-to-sales (or "P/S") ratio of 0.9x might make it look like a buy right now...

Despite an already strong run, Ironwood Pharmaceuticals, Inc. ( NASDAQ:IRWD ) shares have been powering on, with a gain...

It is doubtless a positive to see that the Tilly's, Inc. ( NYSE:TLYS ) share price has gained some 66% in the last...